Dr. Stephen Nimer: Challenges in Hematologic Cancer Treatment | Ep. 04
No se pudo agregar al carrito
Add to Cart failed.
Error al Agregar a Lista de Deseos.
Error al eliminar de la lista de deseos.
Error al añadir a tu biblioteca
Error al seguir el podcast
Error al dejar de seguir el podcast
Dr. Stephen Nimer: Challenges in Hematologic Cancer Treatment | Ep. 04
-
Narrado por:
-
De:
In this episode of The Oncology Insights Podcast, I speak with Dr. Stephen Nimer, Director of the Sylvester Comprehensive Cancer Center at the University of Miami. We explore his remarkable journey from physician-scientist to national leader in hematologic oncology, focusing on acute myelogenous leukemia (AML) and myelodysplastic syndromes (MDS). We also discuss cellular therapy, precision medicine, and the challenges of translational research in today’s oncology landscape. Listen now on all major platforms!
“Understanding the interplay between leukemia cells and their microenvironment is essential to identifying effective new therapeutic targets.”
Meet the guest: Dr. Stephen Nimer is the Director of the Sylvester Comprehensive Cancer Center and Executive Dean for Research at the University of Miami Miller School of Medicine. A leading physician-scientist in hematology-oncology, his research focuses on myelodysplastic syndromes and acute myelogenous leukemia, advancing translational science and patient care.
Liked this one? Don’t stop now. Here’s what we think you’ll love!
What you will learn:
- (00:00) Highlight
- (00:45) Introduction
- (12:59) AML treatment challenges
- (23:22) MDS overview
- (30:17) Animal research ethics
- (33:32) Leadership strategy
- (37:14) Precision medicine
- (38:52) Final Questions
𝗟𝗶𝘀𝘁𝗲𝗻 𝗼𝗻 𝗔𝗽𝗽𝗹𝗲 𝗣𝗼𝗱𝗰𝗮𝘀𝘁𝘀, 𝗦𝗽𝗼𝘁𝗶𝗳𝘆 𝗼𝗿 𝗮𝗻𝘆 𝗺𝗮𝗷𝗼𝗿 𝗽𝗹𝗮𝘁𝗳𝗼𝗿𝗺.
Website: The Oncology Insights Podcast
Instagram: The Oncology Insights Podcast
LinkedIn: The Oncology Insights Podcast